Latest News
Get real-time updates on the latest news and developments in the pharmaceutical world. Stay informed about new drug launches, research findings, regulatory changes, and industry updates. Explore a wide range of topics and stay connected with the rapidly evolving world of pharma.
FDA doubts Onpattro’s benefit in heart disease, Alnylam faces Pfizer hurdle
The FDA has raised significant concerns about Alnylam’s attempt to expand the use of Onpattro for the treatment of transthyretin ...
Sandoz to market Samsung Bioepis’ biosimilar of Stelara in US and Canada
Sandoz is expanding its biosimilar portfolio by signing a commercialization agreement with Samsung Bioepis for a biosimilar version of Johnson ...
Walgreens to pay $44 million to customers who bought faulty Theranos blood tests
Walgreens has reached a settlement in a long-running class-action case related to patients who underwent fraudulent blood tests provided by ...
Moderna expands cancer vaccine portfolio with Immatics deal worth up to $1.7B
Moderna is intensifying its focus on cancer vaccines and cell therapies through a newly announced research partnership with Immatics, a ...
Novartis drops Gyroscope’s gene therapy for eye disease after disappointing trial results
Novartis is in the process of divesting its eye disease unit, a move that includes discontinuing a geographic atrophy (GA) ...
Novo Nordisk’s Wegovy boosts heart health, J.P. Morgan predicts $71B GLP-1 market by 2032
The demand for Novo Nordisk’s obesity medications is surging, with production capacity being the primary limiting factor in the short ...
Nurix and Seagen Join Forces to Pioneer Cancer Therapies by Combining Protein Degradation and ADC Technologies
Seagen has just sealed a strategic partnership with Nurix Therapeutics, headquartered in San Francisco. This collaboration is poised to unlock ...
Eli Lilly’s Mounjaro gets NICE approval for type 2 diabetes after cost-effectiveness review
Eli Lilly’s diabetes medication, Mounjaro (tirzepatide), has been on a winning streak since its US launch in May, and now ...
BMS faces lawsuit for allegedly extending Pomalyst monopoly with fraudulent patents and payoffs
Bristol Myers Squibb (BMS) and Celgene’s widely-used multiple myeloma treatment, Pomalyst, has found itself entangled in a legal battle after ...
Roche’s subcutaneous Tecentriq faces FDA setback due to manufacturing updates
Roche may experience a delay in the FDA decision for its subcutaneous version of the cancer immunotherapy Tecentriq, as it ...
Pfizer CEO supports migraine sufferers and urges employers to do the same
Pfizer’s CEO, Dr. Albert Bourla, is championing a disease awareness campaign by leveraging his social media platforms to underscore the ...
AstraZeneca and Verge partner to discover AI-driven drugs for rare neurodegenerative diseases
Verge Genomics is expanding its roster of Big Pharma partnerships by teaming up with AstraZeneca in a substantial $42 million ...
Asensus and Nvidia team up to boost AI-powered digital surgery solutions
Asensus Surgical, despite having secured approvals for its robotic and AI tools, is not resting on its laurels. The company ...
Ibex raises $55M to expand its AI-powered cancer diagnostics in the US and beyond
Ibex Medical Analytics, an Israeli startup specializing in Artificial intelligence-powered cancer diagnostics, has secured an impressive $55 million in funding ...
ILiAD’s nasal vaccine prevents whooping cough infection in phase 2b trial
ILiAD Biotechnologies, a Florida-based biotech company, is celebrating a significant milestone in the development of its whooping cough vaccine. In ...
Otsuka and Shape Therapeutics join forces to create gene therapies for eye diseases using AI-powered platform
Just a week after Otsuka Pharmaceutical ventured into the psychedelics sector, the Japanese pharmaceutical giant has struck a collaboration deal ...
J&J’s Rybrevant Beats Chemo In Lung Cancer Patients Who Failed Tagrisso
The medical community buzzed with anticipation when Johnson & Johnson (J&J) released information about Rybrevant, their latest drug venture into ...
Takeda Ordered To Pay AbbVie $480m For Failing To Supply Lupron
AbbVie stands to potentially receive significant damages, possibly amounting to hundreds of millions of dollars, due to a contractual manufacturing ...
BlueWhale Bio Emerges With $18m To Tackle Cell Therapy Manufacturing Challenges
BlueWhale Bio, a spinout from the University of Pennsylvania, has emerged with a bold mission to tackle bottlenecks in the ...
PhRMA Launches New Ad Campaign Against PBMs Over Pharmacy Choice
PhRMA has once again mobilized its attack ad team to launch a fresh assault on pharmacy benefit managers (PBMs), this ...
Permira Buys Out CRO Ergomed For £703 Million In Private Deal
Permira, the London-based private equity firm, has made a substantial investment of 703 million pounds sterling (equivalent to $886 million) ...
Vaxart’s Oral Norovirus Vaccine Misses Primary Endpoint But Shows Some Efficacy In Phase 2
Vaxart finds itself in a precarious position as it grapples with mixed results for its oral monovalent norovirus vaccine candidate, ...
Pfizer’s Lyme Vaccine Shows Strong Booster And Pediatric Effects In Phase 2
Pfizer and Valneva are making strides in their Lyme disease vaccine program, achieving a significant milestone by demonstrating the safety ...
Roche’s $310 Million Gamble On Alnylam Pays Off As Hypertension Drug Shows Promise In Phase 2
Roche’s recent investment of $310 million into metabolic therapy is yielding positive results, as its collaboration with Alnylam in the ...
Moody’s Says IRA Price Negotiations Will Have A Modest Impact On Pharma Industry By 2026
With the Centers for Medicare & Medicaid Services (CMS) unveiling the initial list of 10 drugs set to undergo Medicare ...
Janssen CarePath Patient Assistance Program Hit By Data Breach, IBM Reports
A technical vulnerability has led to “unauthorized access” to personal data within Johnson & Johnson’s Janssen CarePath patient assistance program, ...
Singapore’s Hiro Acquires US Oncology CRO To Expand Its Global Footprint
Singapore-based Harvest Integrated Research Organization, known as HiRO, is making a significant move to bolster its global presence through the ...
Novo Nordisk Renews Partnership With Harvard And Broad Institute To Discover New Diabetes And Heart Disease Drugs
Novo Nordisk has announced a collaborative effort with Harvard University and the Broad Institute of MIT to embark on a ...
Janssen Drops Cidara’s Flu Medicine After Disappointing Phase 2 Results
Janssen is honoring its 2021 agreement with Cidara Therapeutics regarding the development of CD388, a flu prophylaxis treatment. However, Janssen ...
Royalty Pharma Pays $150M To Ascendis For A Share Of Skytrofa Sales
Royalty Pharma, renowned for its investments in exchange for long-term drug royalties, has entered into a collaboration with Ascendis Pharma ...
